Skip to main content

Site notifications

Advanced therapies

Find out how we define and regulate advanced therapies, which include gene, cell and tissue treatments.

Advanced therapies or advanced therapy medical products is a term used to describe innovative therapies. International regulators use this term to include gene, cell and tissue therapies.

The TGA uses the following definition for advanced therapies:

  1. Gene therapies
    1. the substance is used in or administered to human beings to regulate, repair, replace, add or delete a genetic sequence

      AND

    2. the substance is involved in the therapeutic, prophylactic, or diagnostic effect of the product
  2. Gene modified cell therapies
  3. Cell and tissue therapies that:
    1. are not devices
    2. have been classified as class 3 or 4 biologicals.
  4. Either a or b in combination with a device

Key information

Help us improve the Therapeutic Goods Administration site